Key result
CMR tissue characterization detects tissue changes before functional decline in doxorubicin-induced cardiotoxicity.
Answers are grounded in this paper and cite their sources.
CMR tissue characterization may flag preclinical anthracycline toxicity; hypothesis-generating and should not yet alter practice or trial design.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Connelly et al. (2019) studied this question. Cardiac magnetic resonance-based tissue characterization identifies changes in tissue composition prior to alterations in cardiac function during doxorubicin-induced cardiotoxicity.
Synapse has enriched 10 related papers. Consider them for comparative context: